In the same year, the same group of researchers co-expressed B7-H6–specific CAR and the transcription factor T-bet (T-box expressed in T cells); CD4+ T cells were found to enhance the toxicity to B7-H6+ tumor cells and improve survival in a RMA/B7-H6 lymphoma mouse model (127). This evidence concerns the gene NCR3LG1 and neoplasm.